Transcript levels of androgen receptor variant AR-V1 or AR-V7 do not predict recurrence in patients with prostate cancer at indeterminate risk for progression

Journal of Urology

Volumn 188, Issue 6, 2012, Pages 2158-2164

  Zhao, Hongjuan ^a   Coram, Marc A ^a   Nolley, Rosalie ^a   Reese, Stephen W ^a   Young, Sarah R ^a   Peehl, Donna M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

neoplasm recurrence, local; prostate; prostate specific antigen; prostatic neoplasms; receptors, androgen

Indexed keywords

ANDROGEN RECEPTOR; DNA; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER RECURRENCE; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DNA DETERMINATION; GENE EXPRESSION; GENE FUSION; GENETIC TRANSCRIPTION; GLEASON SCORE; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECURRENCE RISK; SPLICING DEFECT;

AGED; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RECURRENCE; RISK; TUMOR MARKERS, BIOLOGICAL;

EID: 84869095013     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.08.014     Document Type: Article

References (30)

1. K.R. Lamont, D.J. Tindall Minireview: alternative activation pathways for the androgen receptor in prostate cancer Mol Endocrinol 25 2011 897
2. R. Hu, T.A. Dunn, S. Wei Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer Cancer Res 69 2009 16
3. Z. Guo, X. Yang, F. Sun A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth Cancer Res 69 2009 2305
4. E. Hornberg, E.B. Ylitalo, S. Crnalic Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival PLoS One 6 2011 e19059
5. P.A. Watson, Y.F. Chen, M.D. Balbas Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor Proc Natl Acad Sci U S A 107 2010 16759
6. A.V. D'Amico, R. Whittington, S.B. Malkowicz Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era Cancer 95 2002 281
7. S.F. Shariat, P.I. Karakiewicz, C.G. Roehrborn An updated catalog of prostate cancer predictive tools Cancer 113 2008 3075
8. A.J. Stephenson, P.T. Scardino, J.A. Eastham Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy J Natl Cancer Inst 98 2006 715
9. T.A. Stamey, J.E. McNeal, C.M. Yemoto Biological determinants of cancer progression in men with prostate cancer JAMA 281 1999 1395
10. M.J. Kwon, E. Oh, S. Lee Identification of novel reference genes using multiplatform expression data and their validation for quantitative gene expression analysis PLoS One 4 2009 e6162
11. J. Rubio-Briones, A. Fernandez-Serra, A. Calatrava Clinical implications of TMPRSS2-ERG gene fusion expression in patients with prostate cancer treated with radical prostatectomy J Urol 183 2010 2054
12. A.J. Stephenson, M.W. Kattan, J.A. Eastham Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition J Clin Oncol 24 2006 3973
13. B.S. Knudsen, A.N. Allen, D.F. McLerran Evaluation of the branched-chain DNA assay for measurement of RNA in formalin-fixed tissues J Mol Diagn 10 2008 169
14. J.W. Mellors, C.R. Rinaldo Jr, P. Gupta Prognosis in HIV-1 infection predicted by the quantity of virus in plasma Science 272 1996 1167
15. H.L. Zaaijer, F. ter Borg, H.T. Cuypers Comparison of methods for detection of hepatitis B virus DNA J Clin Microbiol 32 1994 2088
16. H.L. Davis, M.L. Michel, M. Mancini Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen Vaccine 12 1994 1503
17. H. Zhao, R. Nolley, Z. Chen Tissue slice grafts: an in vivo model of human prostate androgen signaling Am J Pathol 177 2010 229
18. R: A language and environment for statistical computing. Team RDC 2010 R Foundation for Statistical Computing Vienna, Austria 409
19. M. Braun, D. Goltz, Z. Shaikhibrahim ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer-a comparative study of two monoclonal antibodies Prostate Cancer Prostatic Dis 15 2012 165
20. A.M. Hoogland, G. Jenster, W.M. van Weerden ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer Mod Pathol 25 2011 471
21. S. Minner, M. Enodien, H. Sirma ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy Clin Cancer Res 17 2011 5878
22. B.G. Barwick, M. Abramovitz, M. Kodani Prostate cancer genes associated with TMPRSS2-ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts Br J Cancer 102 2010 570
23. M.C. Haffner, M.J. Aryee, A. Toubaji Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements Nat Genet 42 2010 668
24. M. Andreoiu, L. Cheng Multifocal prostate cancer: biologic, prognostic, and therapeutic implications Hum Pathol 41 2010 781
25. L. Cheng, D.D. Davidson, H. Lin Percentage of Gleason pattern 4 and 5 predicts survival after radical prostatectomy Cancer 110 2007 1967
26. S. Sun, C.C. Sprenger, R.L. Vessella Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant J Clin Invest 120 2010 2715
27. S.M. Harman, E.J. Metter, J.D. Tobin Longitudinal effects of aging on serum total and free testosterone levels in healthy men Baltimore Longitudinal Study of Aging J Clin Endocrinol Metab 86 2001 724
28. L.W. Harries, D. Hernandez, W. Henley Human aging is characterized by focused changes in gene expression and deregulation of alternative splicing Aging Cell 10 2011 868
29. X. Zhang, C. Morrissey, S. Sun Androgen receptor variants occur frequently in castration resistant prostate cancer metastases PLoS One 6 2011 e27970
30. R. Hu, W.B. Isaacs, J. Luo A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities Prostate 71 2011 1656